Login
Discover
Waves
Decks
Plus
Login
Signup
gut50
@gut50
25
Followers
1
Following
0
Resource Credits
Available
Used
Created
May 1, 2019
RSS Feed
Subscribe
Blog
Blog
Posts
Comments
Communities
Wallet
gut50
theragenomics
2019-05-16 14:49
Febuxostat (Uloric) and its problem with cardiovascular mortality
Despite drug safety problems of cardiovascular mortality with Febuxostat (Uloric), the benefits might still be seen to outweigh risks for selected gout patients. This notion may become more and more disputed,
$ 0.000
1
2
gut50
theragenomics
2019-05-04 07:15
Grossesse et risques de malformations: Il n'y a pas seulement le valproate
may 01, 2019 - En France, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) viens de publier une analyse des données disponibles sur le risque de malformations et de troubles
$ 0.000
4
1
gut50
theragenomics
2019-05-02 04:55
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients
Lemtrada: Deleterious unwanted effects in some multiple sclerosis patients Alemtuzumab (Lemtrada) is used in the treatment of multiple sclerosis (MS). Moreover, Alemtuzumab, under the Tradenames of Campt,
$ 0.000
4
